 |
PDBsum entry 3g0c
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
3g0c
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of dipeptidyl peptidase iv in complex with a pyrimidinedione inhibitor 1
|
|
Structure:
|
 |
Dipeptidyl peptidase 4. Chain: a, b, c, d. Fragment: unp residues 39-766. Synonym: dipeptidyl peptidase iv, dpp iv, t-cell activation antigen cd26, tp103, adenosine deaminase complexing protein 2, adabp, dipeptidyl peptidase 4 membrane form, dipeptidyl peptidase iv membrane form, dipeptidyl peptidase 4 soluble form, dipeptidyl peptidase iv soluble form. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: adcp2, cd26, dpp4. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf9.
|
|
Resolution:
|
 |
|
2.69Å
|
R-factor:
|
0.198
|
R-free:
|
0.248
|
|
|
Authors:
|
 |
Z.Zhang,M.B.Wallace,J.Feng,J.A.Stafford,S.W.Kaldor,L.Shi,R.J.Skene, K.Aertgeerts,B.Lee,A.Jennings,R.Xu,D.Kassel,D.R.Webb,S.L.Gwaltney
|
|
Key ref:
|
 |
Z.Zhang
et al.
(2011).
Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV.
J Med Chem,
54,
510-524.
PubMed id:
|
 |
|
Date:
|
 |
|
27-Jan-09
|
Release date:
|
16-Feb-10
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P27487
(DPP4_HUMAN) -
Dipeptidyl peptidase 4 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
766 a.a.
723 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.14.5
- dipeptidyl-peptidase Iv.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Release of an N-terminal dipeptide, Xaa-Xbb-|-Xcc, from a polypeptide, preferentially when Xbb is Pro, provided Xcc is neither Pro nor hydroxyproline.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Med Chem
54:510-524
(2011)
|
|
PubMed id:
|
|
|
|
|
| |
|
Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV.
|
|
Z.Zhang,
M.B.Wallace,
J.Feng,
J.A.Stafford,
R.J.Skene,
L.Shi,
B.Lee,
K.Aertgeerts,
A.Jennings,
R.Xu,
D.B.Kassel,
S.W.Kaldor,
M.Navre,
D.R.Webb,
S.L.Gwaltney.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |